Jiyi Xia

963 total citations
33 papers, 794 citations indexed

About

Jiyi Xia is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Jiyi Xia has authored 33 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Pharmacology. Recurrent topics in Jiyi Xia's work include Flavonoids in Medical Research (8 papers), Natural product bioactivities and synthesis (7 papers) and Sexual function and dysfunction studies (5 papers). Jiyi Xia is often cited by papers focused on Flavonoids in Medical Research (8 papers), Natural product bioactivities and synthesis (7 papers) and Sexual function and dysfunction studies (5 papers). Jiyi Xia collaborates with scholars based in China, United States and South Korea. Jiyi Xia's co-authors include Xiaolan Yu, Li Tang, Yingcheng Yang, Yong Cao, Tao He, Gang Li, Xiaolan Yu, Meiping Ren, Jianbo Wu and Xiaoping Tang and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, The International Journal of Biochemistry & Cell Biology and Journal of Cellular Biochemistry.

In The Last Decade

Jiyi Xia

33 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiyi Xia China	17	463	262	127	98	82	33	794
Jingyi Guo China	10	366 0.8×	164 0.6×	29 0.2×	128 1.3×	124 1.5×	28	816
Marta Stojak Poland	17	339 0.7×	111 0.4×	33 0.3×	125 1.3×	65 0.8×	43	718
Xinrui Zhao China	14	436 0.9×	172 0.7×	46 0.4×	148 1.5×	140 1.7×	24	874
Zheng Wan China	17	280 0.6×	92 0.4×	61 0.5×	70 0.7×	80 1.0×	57	716
Yu Ran Lee South Korea	18	455 1.0×	67 0.3×	30 0.2×	121 1.2×	86 1.0×	43	704
Bodo Haas Germany	13	522 1.1×	229 0.9×	51 0.4×	152 1.6×	196 2.4×	29	1.1k
Agnieszka Piwkowska Poland	19	584 1.3×	51 0.2×	37 0.3×	82 0.8×	117 1.4×	69	1.3k
Shikun Yang China	16	444 1.0×	187 0.7×	43 0.3×	127 1.3×	136 1.7×	35	773
WU Wei-kang China	12	325 0.7×	60 0.2×	64 0.5×	79 0.8×	194 2.4×	37	860

Countries citing papers authored by Jiyi Xia

Since Specialization

Citations

This map shows the geographic impact of Jiyi Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiyi Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiyi Xia more than expected).

Fields of papers citing papers by Jiyi Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiyi Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiyi Xia. The network helps show where Jiyi Xia may publish in the future.

Co-authorship network of co-authors of Jiyi Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Jiyi Xia. A scholar is included among the top collaborators of Jiyi Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiyi Xia. Jiyi Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Xiaolan, et al.. (2021). miR-381 Reverses Multidrug Resistance by Negative Regulation of the CTNNB1/ABCB1 Pathway in HepG2/Dox Cells, and the Diagnostic and Prognostic Values of CTNNB1 / ABCB1 Are Identified in Patients with LIHC. DNA and Cell Biology. 40(12). 1584–1596. 3 indexed citations

Yu, Xiaolan, Wei Tang, Yingcheng Yang, et al.. (2018). Long noncoding RNA NKILA enhances the anti-cancer effects of baicalein in hepatocellular carcinoma via the regulation of NF-κB signaling. Chemico-Biological Interactions. 285. 48–58. 60 indexed citations

Long, Hao, Jun Jiang, Jiyi Xia, & Rui Jiang. (2018). Icariin improves SHR erectile function via inhibiting eNOS uncoupling. Andrologia. 50(9). e13084–e13084. 12 indexed citations

Liu, Pan, Jun Jiang, Jiyi Xia, & Rui Jiang. (2018). Effect of Low Androgen Status on the Expression of P2Y Receptors in the Corpus Cavernosum of Rats. Urology. 116. 229.e1–229.e6. 7 indexed citations

He, Kai, Xiaolan Yu, Xiaoyan Wang, et al.. (2018). Baicalein and Ly294002 induces liver cancer cells apoptosis via regulating phosphatidyl inositol 3-kinase/Akt signaling pathway. Journal of Cancer Research and Therapeutics. 14(Suppl 2). S519–S525. 28 indexed citations

Yu, Xiaolan, et al.. (2018). Baicalein inhibits breast cancer growth via activating a novel isoform of the long noncoding RNA PAX8‐AS1‐N. Journal of Cellular Biochemistry. 119(8). 6842–6856. 43 indexed citations

Yu, Xiaolan, et al.. (2018). Baicalein induces cervical cancer apoptosis through the NF-κB signaling pathway. Molecular Medicine Reports. 17(4). 5088–5094. 29 indexed citations

Yu, Xiaolan, et al.. (2017). Baicalein suppresses the proliferation of human cervical cancer cells via Notch 1/Hes signaling pathway. Journal of Cancer Research and Therapeutics. 15(6). 1216–1216. 26 indexed citations

Zhang, Yujiao, et al.. (2017). The restraining effect of baicalein and U0126 on human cervical cancer cell line HeLa. Molecular Medicine Reports. 16(1). 957–963. 18 indexed citations

10.

Yu, Xiaolan, et al.. (2016). MiR-486-3p targeting ECM1 represses cell proliferation and metastasis in cervical cancer. Biomedicine & Pharmacotherapy. 80. 109–114. 56 indexed citations

11.

Li, Gang�, Jiyi Xia, Jing Li, et al.. (2016). The diagnostic value of plasma N-terminal connective tissue growth factor levels in children with heart failure. Cardiology in the Young. 27(1). 101–108. 3 indexed citations

12.

Liu, Ling, et al.. (2016). [Knockdown of angiopoietin-like protein 4 inhibits proliferation and promotes apoptosis in cervical cancer SiHa cells].. PubMed. 32(4). 488–92. 2 indexed citations

13.

Xia, Jiyi, et al.. (2016). Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells. Molecular Medicine Reports. 15(1). 488–494. 27 indexed citations

14.

Luo, Mao, Rong Li, Xin Deng, et al.. (2015). Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes. Acta Diabetologica. 52(5). 943–949. 34 indexed citations

15.

Xia, Jiyi, et al.. (2015). Effects of estrogen deprivation on expression of aquaporins in rat vagina. Menopause The Journal of The North American Menopause Society. 22(8). 893–898. 13 indexed citations

16.

Xia, Jiyi, et al.. (2015). Plasma Levels of Acylated Ghrelin in Children with Pulmonary Hypertension Associated with Congenital Heart Disease. Pediatric Cardiology. 36(7). 1423–1428. 11 indexed citations

17.

Xia, Jiyi, Xiaolan Yu, Li Tang, Gang Li, & Tao He. (2015). P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway. Oncology Reports. 34(1). 103–110. 96 indexed citations

18.

Yu, Xiaolan, et al.. (2015). Retinoic acid aliphatic amide inhibits the AMPK-HIF-1α pathway in human ovarian cancer.. PubMed Central. 8(6). 6416–24. 2 indexed citations

19.

Li, Rong, Mao Luo, Meiping Ren, et al.. (2014). Vitronectin Regulation of Vascular Endothelial Growth Factor-Mediated Angiogenesis. Journal of Vascular Research. 51(2). 110–117. 20 indexed citations

20.

Ren, Meiping, Ni Chen, Mao Luo, et al.. (2014). Presence of intratumoral platelets is associated with tumor vessel structure and metastasis. BMC Cancer. 14(1). 167–167. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact